ArticleHemaSphere2026

Idecabtagene vicleucel and endogenous T-cell phenotypes linked to progression-free survival in relapsed multiple myeloma.

Bruno Paiva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.